Related Experiment Videos
Comparative efficacy and safety of cephradine and cephalexin in children
Insights
Cephradine and cephalexin demonstrated equal safety and effectiveness in treating bacterial infections in children. This randomized study found nearly identical clinical and bacteriologic responses for both antibiotics in pediatric practice.
Area of Science:
- Pediatric Infectious Diseases
- Pharmacology and Therapeutics
Background:
- Bacterial infections are common in children.
- Cephalosporins are a class of antibiotics frequently used in pediatric care.
- Comparative efficacy and safety data are crucial for treatment guidelines.
Purpose of the Study:
- To compare the clinical and bacteriologic efficacy of cephradine and cephalexin.
- To assess the relative safety of cephradine versus cephalexin in pediatric patients.
- To evaluate the suitability of both antibiotics for treating common childhood bacterial infections.
Main Methods:
- A randomized, double-blind study involving 162 children aged four months to eleven years.
- Participants received oral suspensions of cephradine or cephalexin for five to fifteen days.
- Clinical and bacteriologic responses, along with safety, were evaluated.
Main Results:
- Nearly identical clinical and bacteriologic responses were observed between the cephradine and cephalexin groups.
- Both antibiotics were found to be equally safe and effective.
- The study included children with lobar pneumonia and skin infections.
Conclusions:
- Cephradine and cephalexin are equally safe and effective treatment options for bacterial infections in children.
- Both antibiotics can be reliably used in pediatric practice.
- The findings support the use of either cephradine or cephalexin based on clinical judgment.
Abstract:
Cephradine was compared to cephalexin a randomized, double-blind study for the treatment of bacterial infections in 162 children between four months and eleven years of age. In addition to evaluations of clinical and bacteriologic responses to therapy, the relative safety of the two cephalosporins was assessed for all children, including eight who were not included in the evaluation of drug efficacy. The children in the efficacy evaluation had either lobar pneumonia or skin infections and received oral suspensions of cephradine (25-110 mg/kg per day) or cephalexin (25-150 mg/kg per day) for five to fifteen days. Overall clinical and bacteriologic responses were nearly identical in the two groups, and both antibiotics proved to equally safe and effective for use paediatric practice.